Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018.

Barnsteiner, Stefanie; Baty, Florent; Albrich, Werner C; Babouee Flury, Baharak; Gasser, Michael; Plüss-Suard, Catherine; Schlegel, Matthias; Kronenberg, Andreas; Kohler, Philipp (2021). Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Eurosurveillance, 26(46) European Centre for Disease Prevention and Control 10.2807/1560-7917.ES.2021.26.46.2001537

[img]
Preview
Text
eurosurv-26-46-4.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (541kB) | Preview

BackgroundIntensive care units (ICU) constitute a high-risk setting for antimicrobial resistance (AMR).AimWe aimed to describe secular AMR trends including meticillin-resistant Staphylococcus aureus (MRSA), glycopeptide-resistant enterococci (GRE), extended-spectrum cephalosporin-resistant Escherichia coli (ESCR-EC) and Klebsiella pneumoniae (ESCR-KP), carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa (CRPA) from Swiss ICU. We assessed time trends of antibiotic consumption and identified factors associated with CRE and CRPA.MethodsWe analysed patient isolate and antibiotic consumption data of Swiss ICU sent to the Swiss Centre for Antibiotic Resistance (2009-2018). Time trends were assessed using linear logistic regression; a mixed-effects logistic regression was used to identify factors associated with CRE and CRPA.ResultsAmong 52 ICU, MRSA decreased from 14% to 6% (p = 0.005; n = 6,465); GRE increased from 1% to 3% (p = 0.011; n = 4,776). ESCR-EC and ESCR-KP increased from 7% to 15% (p < 0.001, n = 10,648) and 5% to 11% (p = 0.002; n = 4,052), respectively. CRE, mostly Enterobacter spp., increased from 1% to 5% (p = 0.008; n = 17,987); CRPA remained stable at 27% (p = 0.759; n = 4,185). Antibiotic consumption in 58 ICU increased from 2009 to 2013 (82.5 to 97.4 defined daily doses (DDD)/100 bed-days) and declined until 2018 (78.3 DDD/100 bed-days). Total institutional antibiotic consumption was associated with detection of CRE in multivariable analysis (odds ratio per DDD: 1.01; 95% confidence interval: 1.0-1.02; p = 0.004).DiscussionIn Swiss ICU, antibiotic-resistant Enterobacterales have been steadily increasing over the last decade. The emergence of CRE, associated with institutional antibiotic consumption, is of particular concern and calls for reinforced surveillance and antibiotic stewardship in this setting.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research

UniBE Contributor:

Gasser, Michael, Plüss, Catherine, Kronenberg, Andreas Oskar

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1560-7917

Publisher:

European Centre for Disease Prevention and Control

Language:

English

Submitter:

Andreas Oskar Kronenberg

Date Deposited:

15 Dec 2021 14:09

Last Modified:

05 Dec 2022 15:55

Publisher DOI:

10.2807/1560-7917.ES.2021.26.46.2001537

PubMed ID:

34794535

Uncontrolled Keywords:

CRE Carbapenem resistance Carbapenem-resistant Enterobacterales Gram-negative bacteria ICU Switzerland antibiotic consumption intensive care

BORIS DOI:

10.48350/161727

URI:

https://boris.unibe.ch/id/eprint/161727

Actions (login required)

Edit item Edit item
Provide Feedback